Imodium · DIN 00860743 · 2 mg · Caplet
Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 1999-06-16 — choose a marketed DIN from the same-category list.Discontinued June 16, 1999 · checked October 5, 2026
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 1999-06-16 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives; Health Canada lists this DIN as Cancelled post market since 1999-06-16 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 110, 111, 112, 113, 114, 115, 224
Coverage limit:
For the treatment of diarrhea associated with:
Reason for Use code 110
An ileostomy or a colostomy;.
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 111
Bowel resection, including short bowel syndrome;
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 112
Inflammatory Bowel Diseases, i.e. Crohn's Disease and Ulcerative Colitis;
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 113
Cancer, including chemotherapy or radiation therapy;
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 114
HIV/AIDS;
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 115
Acute diarrhea in patients in congregated housing, i.e. Long Term Care Facilities (LTCF), or for patients receiving Home Care;
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 224
Fecal incontinence.
Coverage limit:
LU Authorization Period: 1 year
1 brand, same coverage
Imodium · DIN 00860743
Manufacturer: Janssen Inc.; listing date 1996-10-01
Health Canada: Cancelled post market since 1999-06-16 · brand IMODIUM CAPLETS 2MG · ATC A07DA03 LOPERAMIDE · form Tablet · route Oral · ingredients LOPERAMIDE HYDROCHLORIDE 2 MG/TAB · company Janssen pharmaceutica, division of janssen-ortho inc. · schedule Non-prescription drugs
Re-check Health Canada status and shortages (live) · Health Canada product recordImodium: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada); live check failed, extract retained: Health Canada DPD page The read operation timed out · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00860743)
Source record
DIN 00860743: Imodium
Raw flags: notABenefit=Y, sec3=Y
Item: 560800015; group id 647; item number 1626; lccId 00096; manufacturer id JAN
Source form: Caplet; strength: 2mg
Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00860743
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada); live check failed, extract retained: https://health-products.canada.ca/api/drug/drugproduct/?din=00860743&lang=en&type=json: The read operation timed out · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=10543
Interchangeable products
Apo-Loperamide · DIN 02212005 · $0.0952
PMS-Loperamide · DIN 02228351 · $0.0952
Teva-Loperamide · DIN 02132591 · $0.0952
Shortage status: not checked (no credentials)
Health Canada lists this DIN as Cancelled post market since June 16, 1999 — choose a marketed DIN from the same-category list.